AJMC February 2, 2022
Gianna Melillo

The rise in popularity of genetic testing brings along a myriad of challenges ranging from concerns on data privacy to insurance coverage, but, when utilized correctly, it could mark a step forward for significant advancements in individual and population health.

Use of genetic information in health care is not new. Genome-wide association studies (GWAS), next-generation sequencing (NGS), and pharmacogenetics all incorporate different facets of genomics with the purpose of identifying abnormalities linked with disease risk, increasing understanding of disease pathogenesis, and identifying which patients respond best to certain treatments.

Apart from these methodologies most commonly used in scientific research, average Americans may be more familiar with “recreational genetics,” or services offered by companies like 23andMe that provide insights on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article